Adaptive Biotechnologies (ADPT) Capital Expenditures (QoQ) (2018 - 2026)
Adaptive Biotechnologies (ADPT) Capital Expenditures (QoQ) (2018 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Waters | 30,529.42 Bn | 30,528.96 Bn | 1.11 Bn |
| 2 | Thermo Fisher Scientific | 183.75 Bn | 180.50 Bn | 7.74 Bn |
| 3 | Danaher | 133.13 Bn | 127.43 Bn | 3.59 Bn |
| 4 | Idexx Laboratories | 46.14 Bn | 45.94 Bn | 722.74 Mn |
| 5 | Agilent Technologies | 38.20 Bn | 36.39 Bn | 990.00 Mn |
| 6 | Natera | 31.50 Bn | 30.40 Bn | 696.04 Mn |
| 7 | Iqvia Holdings | 31.34 Bn | 29.36 Bn | 1.36 Bn |
| 8 | Illumina | 24.51 Bn | 23.36 Bn | 721.00 Mn |
| 9 | Mettler Toledo International | 23.53 Bn | 23.47 Bn | 555.82 Mn |
| 10 | Adaptive Biotechnologies | 2.71 Bn | 2.50 Bn | 52.17 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -65.26% |
| Dec 31, 2025 | 415.99% |
| Sep 30, 2025 | 3,315.38% |
| Jun 30, 2025 | -93.84% |
| Mar 31, 2025 | 163.75% |
| Dec 31, 2024 | -76.74% |
| Sep 30, 2024 | -83.81% |
| Jun 30, 2024 | 90.58% |
| Mar 31, 2024 | 279.55% |
| Dec 31, 2023 | 88.31% |
| Sep 30, 2023 | -206.90% |
| Jun 30, 2023 | 201.03% |
| Mar 31, 2023 | 283.44% |
| Dec 31, 2022 | -34.93% |
| Sep 30, 2022 | -419.14% |
| Jun 30, 2022 | -93.21% |
| Mar 31, 2022 | 141.30% |
| Dec 31, 2021 | 74.95% |
| Sep 30, 2021 | -234.97% |
| Jun 30, 2021 | 39.14% |